AK002
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AK002, covering 2023-03-03 to 2024-02-28. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis [Phase 2]